• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510800
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ossification (1428); Neuropathy (1983); Loss of Range of Motion (2032); Injury (2348); Numbness (2415); Neck Pain (2433); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4) (revision surgery) neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Note: multiple product were used during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
 
Event Description
It was reported that the patient underwent two spinal fusion surgeries using rhbmp-2/ acs in a posterolateral thoracolumbar fusion surgery and a posterior cervical fusion surgery.On (b)(6) 2006, patient underwent the spinal fusion surgery at t4-l2 levels of her vertebrae.The rhbmp-2 was used to fuse more than one level of the spine using posterior approach.The rhbmp-2 collagen sponge was placed outside a cage in the posterior elements.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported the patient was pre-operatively diagnosed with fixed sagittal imbalance, grossly positive sagittal balance/imbalance, status post multiple laminectomies, fusions, and instrumentations from l1 to the sacrum.Adjacent segment disease at t12-l1,marked thoracolumbar kyphosis and underwent the following procedures: posterolateral spinal fusion from t4 to l2, degenerative kyphotic segments, seven thoracic segments, two lumbar segments, nine segments total, removal of pedicle screw implants from l1 to l3, six pedicle screws, two rods, exploration and fusion from l1 to l3.Revision of posterior segmental spinal instrumentation t4 to l3, pedicle screws all levels, multiaxial screws all levels, twenty-four screws, two rods, 168 milligrams of rhbmp-2, twenty-eight sponges, 140 milliliters of graft, 40 milliliters of local bone graft.Aggressive harvesting of local bone graft, spinal cord monitoring.As per op-notes,¿ surgeon used fourteen kits of bone morphogenic protein.I believe the total dosage was 168 milligrams.The 2 milligrams per milliliters concentration.This generated twenty-eight rolled sponges/fajitas.Each fajita was an acs sponge wrapped over a crm sponge.All soaked in a total bmp.Soaked for over an hour, then converted to a stew and combined with the local bone graft.So the ultimate construct was twenty-four pedicle screws, all multiaxial, two rods 5.5, stainless steel, and then twenty-eight fajitas converted to a stew, 168 milligrams of bone morphogenic protein.Forty milliliters of local bone graft, and 140 milliliters of graft.We did extensive decortication first with lexxel and then with a curved osteotome and a mallet, and all the inner laminar spaces and the lateral transverse processes as well, t11, t12, in particular, out to the tips of the transverse processes at l1 and l2.Then placed the bone graft mixture from t4 to l2.We tightened down and sheared off all the set screws.We decided not to place any cross-links.The construct seemed stable.Actually, the quality of the patient's bone was quite good.She did not appear osteoporotic.We had to work a little bit to get the thoracic pedicle screws in.Her bone was fairly hard actually.¿ the patient tolerated the procedure well without any intra-operative complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key5546786
MDR Text Key41823840
Report Number1030489-2016-00935
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup
Report Date 10/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number7510800
Device Lot NumberM115008AAC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/10/2016
Initial Date FDA Received04/05/2016
Supplement Dates Manufacturer Received03/10/2016
10/09/2017
Supplement Dates FDA Received09/20/2017
10/26/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-